Title Credit Type Event date Cost
Addressing the Cardiometabolic Risk Continuum in MASH: What Clinicians Need to Know
    • 1.00 CDE
    • 1.00 ACPE Pharmacy
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 1.00 Participation
 Enduring $0.00
Clinical Brief: Advancements in Dyslipidemia Treatments and ASCVD Risk Reduction for High-Risk Individuals
    • 0.50 CDE
    • 0.50 ACPE Pharmacy
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 ANCC
    • 0.50 Participation
 Enduring $0.00
Addressing Unmet Needs and Disease Burden in Chronic Spontaneous Urticaria: A Clinical Escape Room Challenge
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 ANCC
    • 0.50 Participation
 Enduring $0.00
JAK is Out of the Box: Leveling Up Care for Severe Alopecia Areata Across Patient Populations
    • 0.75 AAPA Category I CME
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 ANCC
    • 0.75 Participation
 Enduring $0.00
Navigating Cardiorenal Metabolic Complexities: A Case Study of a 64-Year-Old Female with T2D, HTN, CKD, and Obesity
    • 0.50 CDE
    • 0.50 ACPE Pharmacy
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 ANCC
    • 0.50 Participation
 Enduring $0.00
Expanding the AD Toolb-OX: A New Pathway for Treating Moderate-to-Severe Disease
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 1.00 Participation
 Enduring $0.00
Cutting-Edge Wound Care in Dermatology: Addressing Knowledge Gaps and Utilizing Multidisciplinary Strategies
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 Participation
 Enduring $0.00
Navigating the Latest in Pulmonary Arterial Hypertension: Implementing Guidelines Amidst a Changing Treatment Landscape
    • 1.25 ACPE Pharmacy
    • 1.25 AMA PRA Category 1 Credit™
    • 1.25 ANCC
    • 1.25 Participation
 Enduring $0.00
Integrating CGM with GLP-1 RA Therapy: Clinical Evidence, Treatment a Overcoming Barriers in T2DM
    • 1.25 ACPE Pharmacy
    • 1.25 AMA PRA Category 1 Credit™
    • 1.25 ANCC
    • 1.25 Participation
 Enduring $0.00
MASH Uncovered: Essential Insights for Clinicians on Effective Screening, Risk Stratification, and Disease Management
    • 1.25 CDE
    • 1.25 ACPE Pharmacy
    • 1.25 AMA PRA Category 1 Credit™
    • 1.25 ANCC
    • 1.25 Participation
 Enduring $0.00
Innovative Approaches to Managing Resistant/Uncontrolled Hypertension: Screening, Evaluation and Intervention​
    • 0.75 CDE
    • 0.75 ACPE Pharmacy
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 ANCC
    • 0.75 Participation
 Enduring $0.00